Although the ban on funding embryonic stem cells was recently lifted by President Barack Obama, the controversy over this research still remains.New types of pluripotent stem cells have recently emerged as alternatives to embryonic stem cells. These include induced pluripotent stem cells (IPS cells) and parthenogenic stem cells. In this episode of BioTalk, Kent Vrana (1:25) , Ph.D., chair of the department of Pharmacology at Penn State University College of Medicine, and Ken Aldrich (21:55), CEO of International Stem Cell Corporation, discuss the current state of stem cell research.
Why Johnny Can't Clone: An interview with Dr. Ichiro Matsumura on his Practical Guide for best practices in molecular cloning
Reducing contamination in ancient DNA samples: An interview with Drs. Petra Korlević and Matthias Meyer
Antibody Validation | BenchTalk November 2013
Epigenetics Sept 2013 V2
The Translation Research Emphasis | BenchTalk, Episode 14
Behind the Scenes of GE's Cell Imaging Contest | BenchTalk, Episode 13